Krystal Biotech Inc (KRYS) short volume · P/E 39, rev $389.1M
Krystal Biotech Inc FINRA short-volume cache. Latest 2026-10-21.
| Date | Short | Total | Short % |
|---|---|---|---|
| 2026-10-21 | 123,547 | 219,531 | 56.3% |
| 2026-10-20 | 50,128 | 68,737 | 72.9% |
| 2026-10-19 | 52,783 | 82,645 | 63.9% |
| 2026-10-16 | 74,099 | 93,202 | 79.5% |
| 2026-10-15 | 67,814 | 84,803 | 80.0% |
| 2026-10-14 | 63,513 | 85,019 | 74.7% |
| 2026-10-13 | 63,613 | 90,949 | 69.9% |
| 2026-10-12 | 62,663 | 69,229 | 90.5% |
| 2026-10-09 | 57,666 | 70,442 | 81.9% |
| 2026-10-08 | 78,015 | 103,377 | 75.5% |
KRYS short volume FAQ
What was KRYS's latest FINRA short volume?
On Oct 21, 2026, cached FINRA short volume for Krystal Biotech Inc (KRYS) was 123,547 shares, 56.3% of 219,531 total volume.
How many KRYS short-volume sessions are listed on this page?
This page lists 10 cached FINRA short-volume sessions for Krystal Biotech Inc (KRYS), from Oct 8, 2026 through Oct 21, 2026.
How did KRYS short volume percent change from the prior cached session?
Cached FINRA short volume for Krystal Biotech Inc (KRYS) moved from 72.9% on Oct 20, 2026 to 56.3% on Oct 21, 2026, down 16.6 percentage points.
What was the highest KRYS short volume percent on this page?
The highest cached FINRA short volume on this page is 90.5% of total volume on Oct 12, 2026.
Where is KRYS listed?
Krystal Biotech Inc (KRYS) common stock is listed on NASDAQ.
What is KRYS's P/E ratio?
Krystal Biotech Inc (KRYS) trailing P/E is 39.0 on the latest cached fundamentals snapshot.
What is KRYS's latest revenue?
Latest cached Krystal Biotech Inc (KRYS) revenue for Dec 31, 2025 was $389.1M. Statements: https://lician.com/financials/krys
Where is KRYS short volume listed?
Cached FINRA short volume for Krystal Biotech Inc (KRYS) is listed at https://lician.com/short-interest/krys.
Not investment advice. Cached rows, not a live tape.